लोड हो रहा है...
Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge
Objective: The aim of this observational study was to determine the optimal timing of interleukin-6 receptor inhibitor (IL6ri) administration for coronavirus disease 2019 (COVID-19). Methods: Patients with COVID-19 were given an IL6ri (sarilumab or tocilizumab) based on iteratively reviewed guidelin...
में बचाया:
मुख्य लेखकों: | , , , , , , , , , , , , , , , , |
---|---|
स्वरूप: | Artigo |
भाषा: | Inglês |
प्रकाशित: |
Elsevier
2020-10-01
|
श्रृंखला: | International Journal of Infectious Diseases |
विषय: | |
ऑनलाइन पहुंच: | http://www.sciencedirect.com/science/article/pii/S1201971220305683 |
टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|